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Carotid angioplasty with internal carotid artery
flow reversal is well tolerated in the awake patient
Enrique Criado, MD,a Manuel Doblas, MD,b Juan Fontcuberta, MD,b Antonio Orgaz, MD,b Angel
Flores, MD,b Paloma Lopez, MD,b and L Philipp Wall, MD,a Stony Brook, NY; and Toledo, Spain
Objective: The purpose of this study was to evaluate the neurologic tolerance and changes in ipsilateral hemispheric oxygen
saturation during transcervical carotid artery stenting with internal carotid artery (ICA) flow reversal for embolic
protection.
Patients and methods: This was a prospective study of 10 patients (mean age 68 years) undergoing transcervical carotid
angioplasty and stenting. All ICA stenoses were greater that 70%. Seven patients had an ipsilateral hemispheric stroke (3)
or transient ischemic attack (4), two patients had a contralateral stroke, and one patient was asymptomatic. Nine
procedures were done under local anesthesia. Cerebral protection was established through a cervical common carotid
(CCA) cutdown to create an external fistula between the ICA and the internal jugular vein with temporally CCA
occlusion. Venous oxygen saturation (SVO2) was continuously monitored through a catheter placed in the distal internal
jugular vein. Mental status and motor-sensory changes were categorized and assessed throughout and after the procedure.
Results: All procedures were technically successful without significant residual stenosis. Mean ICA flow reversal time was
22 minutes (range, 15 to 32). Common carotid artery (CCA) occlusion produced a slight (SVO2  72.6%/-9.4) but
significant decrease (P  .012) in SVO2, compared with baseline (SVO2  77% /-10.5). During ICA flow reversal
(SVO2  72.4% /-10.1) cerebral oxygen saturation did not change compared with CCA occlusion alone (P  .85).
Transient balloon occlusion during angioplasty of the ICA (SVO2  64.6%/-12.9) produced a significant decrease in
cerebral SVO2 compared with CCA occlusion (P  .015) and compared with CCA occlusion with ICA flow reversal
(P .018). No mental status changes or ipsilateral hemispheric focal symptoms occurred during CCA occlusion with ICA
flow reversal. One patient with contralateral ICA occlusion sustained brief upper extremity weakness related to the
contralateral hemisphere. Five patients sustained a vasovagal response during balloon dilatation, four did not require
treatment, and one had asystole requiring atropine injection. Mean SVO2 saturation was not different in these five
patients compared with the five who did not sustain a vasovagal response. No deaths or neurologic deficits occurred
within 30 days after the procedure.
Conclusions: Our data suggest that transcervical carotid angioplasty and stenting with ICA flow reversal is well tolerated
in the awake patient, even in the presence of symptomatic carotid artery disease. Cerebral oxygenation during ICA flow
reversal is comparable to that during CCA occlusion. ICA angioplasty balloon inflation produces a decrease in cerebral
SVO2 significantly greater than that occurring during ICA flow reversal. (J Vasc Surg 2004;40:92-7.)The beneficial effect of cerebral protection during ca-
rotid artery stenting (CAS) has not yet been proven in
prospective, controlled studies. However, pooled data from
mu´ltiple single institutional experiences suggest that cere-
bral protection during CAS may reduce the risk of cerebral
embolization and neurologic events.1 The risk of cerebral
embolization, detected by postoperative magnetic reso-
nance imaging, is 15% in patients undergoing CAS without
cerebral protection, 7% of whom experience a clinically
apparent neurologic event.2 Current methods under eval-
uation for cerebral protection during CAS include distal
internal carotid artery (ICA) balloon occlusion, distal ICA
filtering, and proximal common carotid artery (CCA) oc-
clusion with or without carotid flow reversal. All these
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doi:10.1016/j.jvs.2004.03.03492methods aim at avoiding distal embolization of carotid
debris to the brain. The Parodi antiembolic femoral cathe-
ter permits constant flow inversion in the ICA by connect-
ing the aspiration port to the femoral vein, creating an
arteriovenous fistula between the ICA and the deep venous
system.3 Arteriovenous flow in this guiding catheter, how-
ever, may be limited because of its high resistance, mainly
when catheters occupy its lumen. Our transcervical tech-
nique for CAS, using a short, larger bore carotid to internal
jugular vein (IJV) fistula, maintains a constant, higher flow
reversal in the ICA without external carotid occlusion.
Preliminary clinical experience suggests that ICA flow re-
versal is effective in preventing cerebral embolism and that
is well tolerated,3 but the physiologic mechanism for neu-
rologic tolerance is not well understood. This study was
designed to evaluate changes in cerebral oxygen saturation
and neurologic status during CCA occlusion and ICA flow
reversal using a transcervical approach for CAS.
PATIENTS AND METHODS
Patient population. During September and October
2003, 10 consecutive patients underwent CAS procedures
as part of a prospective study in accordance with the insti-
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Hospitalario de Toledo, Spain. Informed consent was ob-
tained from all patients. Data was prospectively collected
regarding medical history, comorbidities, symptomatic sta-
tus, degree of carotid stenosis, and intraoperative and post-
operative studies and events.
Patient mean age was 68 years (range, 59-80 years). All
patients were men. Seven patients had symptomatic carotid
stenosis, four with hemispheric transient ischemic attack
and three with a previous ipsilateral hemispheric stroke.
Three patients had asymptomatic carotid stenosis; two of
them with previous contralateral hemispheric stroke. The
indications for carotid intervention and estimated degree of
carotid stenosis are delineated in Table I. Associated med-
ical comorbid conditions are summarized in Table II.
Transcervical CAS protocol and technique. All pa-
tients underwent carotid duplex ultrasound scanning to
confirm the degree of carotid stenosis. All patients were
treated with aspirin, 325 mg/d, and clopidogrel, 75 mg
once a day for at least 4 days, or 300 mg a day for 2 days
before the procedure. Nine interventions were done under
local anesthesia (1% lidocaine), and one patient received
general anesthesia upon his request at the initiation of the
operation. No sedation was given before or during the
procedure. One hundred units of heparin per kilogram of
body weight were given intravenously before carotid punc-
ture. Intra-arterial blood pressure and transcutaneous oxy-
gen saturation were continuously monitored, and neuro-
logic status was assessed at regular intervals by the
Table I. Indications and degree of ICA stenosis* in 10 pat
Patient Indication
1 Previous contralateral CVA
2 Previous ipsilateral CVA
3 Asymptomatic
4 Hemispheric TIA
5 Previous ipsilateral CVA
6 Hemispheric TIA
7 Previous contralateral CVA
8 Hemispheric TIA
9 Hemispheric TIA
10 Previous ipsilateral CVA
ICA, Internal carotid artery; CAS, carotid artery stenting; CVA, cerebrovas
*The % of ICA stenosis was estimated based on duplex.
Table II. Medical comorbidities in 10 patients
undergoing CAS
Medical comorbidity No. %
CAD 4 40
CAD with coronary intervention 3 30
Hypercholesterolemia 4 40
Hypertension 8 80
Diabetes 2 20
Smoking 2 20
CAD, Coronary artery disease.anesthesiologist and surgeon. Ipsilateral, hemispheric ve-
nous oxygen saturation (SVO2) was recorded after place-
ment of all vessel introducer sheaths without vessel occlu-
sion (baseline), after occlusion of the CCA maintaining
external to internal carotid flow until SVO2 stabilized
within 1 to 2 minutes, after establishment of ICA flow
reversal with CCA occlusion, after occlusion of the ICA
during angioplasty balloon inflation, and after returning to
baseline.
We used a technique for transcervical CAS that we
previously developed through experience in 30 patients. A
full description of our technique has been published.4
Basically, the technique consists in accessing the common
carotid artery through a mini-incision (3 to 4 cm) at the
base of the neck, encircling the proximal CCA with a
Rummel loop, and establishing an arteriovenous fistula
between the CCA and the IJV by placing 8F by 11-cm
percutaneous introducer sheaths (Super Arrow Flex; Arrow
International, Reading, Pa) in these vessels and connecting
the introducers with a short (15-cm) segment of tubing
(Fig 1). For this study exclusively, ipsilateral hemispheric
SVO2 was continuously measured with a pediatric oxymet-
ric Swan-Ganz catheter, introduced through a 5F by 11-cm
percutaneous introducer sheath (Super Arrow Flex) from
the neck incision into the IJV in a cephalad direction.
After the CCA was occluded with the Rummel loop
and a carotid to jugular fistula was established, retrograde
flow in the ICA was ascertained with fluoroscopy by inject-
ing a small amount of contrast in the CCA and immediately
opening the fistula to observe contrast drain from the ICA
into the IJV (Fig 2). There is no need to balloon occlude
the external carotid, because the resistance of the fistula is
low enough to reverse flow in both the external and internal
carotids. Using hand injection, digital angiography was
performed in the lateral and oblique planes to localize and
quantitate the degree of ICA stenosis. With flow reversal in
place, a 0.014-inch guide wire (Platinum plus TM, ST,
0.014-180 cm; Boston Scientific, Meditech, Miami, Fla) in
a 4F by 40-cm-long Berenstein catheter (Angiodynamics,
Inc, Queensbury, NY) was introduced through the CCA
sheath for selective crossing of the ICA stenosis. The tip of
undergoing CAS
Ipsilateral stenosis
(%)
Contralateral stenosis
(%)
70 50
80 50
80 50
70 occluded
70 70
70 50
80 occluded
70 50
80 50
80 80
accident; TIA, transient ischemic attack.ients
cular
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carotid siphon.
No predilatation of the lesion was done in this group of
patients. Self-expandable monorail stents 10  31 mm or
10  37 mm (Wallstent; Boston Scientific, Maple Grove,
Minn) were used in all patients. Post-stent dilation was
performed for 5 to 10 seconds in all cases with 5- or 6-mm
 2-cm monorail balloon catheters (Ultra-soft SV Mono-
rail balloon catheter; Boston Scientific, Maple Grove,
Minn) inflated to 8 atm.
Ipsilateral hemispheric IJV oxygen saturation was re-
corded at baseline with all sheaths in place, after occluding
the CCA without arteriovenous fistula for 1 to 2 minutes,
after stabilization with the CCA occluded and the arterio-
venous fistula functioning, immediately after occluding the
ICA during balloon dilatation, and upon return to baseline
after stent placement. Intra-arterial blood pressure, heart
rate, and neurologic status were monitored throughout the
procedure.
A completion carotid angiography was performed to
assess technical results and the presence of distal spasm.
Intra-arterial papaverine solution (1 mg/mL) was selec-
tively used to treat residual post-CAS spasm. Following
Fig 1. Diagram illustrating the arteriovenous fistula between the
common carotid artery and the internal jugular vein.removal of the sheaths, the vessel access sites were closed
with 6-0 polypropylene sutures, and the wound was closed
with absorbable sutures. After the procedure, all patients
were observed in the recovery room for 6 hours and then
transferred to a floor bed. The following day, after a phys-
ical examination, all patients were discharged from the
hospital.
Clopidogrel was continued at 75 mg/d by mouth for at
least 1 month, and aspirin was continued indefinitely. One
month following the procedure, a physical examination and
a carotid duplex scan were repeated in all patients. Techni-
cal failure was defined as inability to access or to cross the
lesion or post-stenting residual stenosis equal or greater
than 30%. Intraprocedural mental status changes were cat-
egorized as none, somehow decreased, or unresponsive. Tran-
sient ischemic attack was defined as a focal hemispheric
deficit that resolved within 24 hours. A focal deficit lasting
more than 24 hours was defined as a stroke. Recurrent or
residual in stent stenosis was defined as more than 50%
diameter reduction as determined by duplex ultrasound
scanning.
Statistical analysis was done with a personal computer
and an SPSS (version 11) statistical package. Paired groups
of data were compared using the paired Student t test.
Unpaired data was compared using the independent vari-
able Student t test.
RESULTS
All CAS procedures were accomplished successfully.
No contrast extravasation, arterial disruption, or subintimal
dissections were observed. Distal ICA spasm following CAS
was found in one patient, and resolved with papaverine
injection. Mean duration of the procedure was 62 minutes
(range, 45-80), and mean ICA flow reversal time was 22
minutes (range, 15-32). Residual stenosis after CAS did
not exceed 15% in any case, and the external carotid artery
remained patent in all patients.
There were no intraoperative ipsilateral hemispheric
focal deficits. No mental status changes occurred in re-
sponse to CCA occlusion or ICA flow reversal. One patient
with contralateral ICA occlusion and previous contralateral
hemispheric stroke sustained transient upper extremity
weakness related to the contralateral hemisphere and the
end of the ICA flow reversal period, which resolved upon
re-establishing antegrade carotid flow. Another patient had
a seizure following injection of papaverine solution in ex-
cessive concentration (30 mg/mL instead of 1 mg/mL) to
resolve residual ICA spasm following CAS after antegrade
ICA was re-established. The patient was given intravenous
benzodiazepines, intubated, and extubated within 30 min-
utes without sequelae. Five patients sustained a decrease in
pulse rate and blood pressure in response to ICA balloon
dilatation. In four of these cases the carotid body response
was mild and did not require treatment; one patient sus-
tained asystole, recovering pulse and pressure after a pre-
cordial thump and atropine administration, and subse-
quently required a pacemaker.
the p
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patients were discharged the day after the procedure. There
were no deaths or strokes at 30 days following surgery.
All patients were followed up within 1 to 2 months
following the procedure. At the time of follow-up, all
patients remained neurologically unchanged, and carotid
ultrasound revealed that all stents were patent without
residual or recurrent stenosis.
Hemispheric mixed venous oxygen saturation mean
changes with standard deviations during the procedure are
depicted in Fig 3. CCA occlusion with external to internal
carotid flow produced a mild drop in cerebral SVO2 com-
pared with baseline (77% vs 72.6%); this difference, how-
ever, was statistically significant (P  .012). During ICA
flow reversal, the SVO2 remained unchanged (P  .85)
compared with CCA occlusion with external to internal
flow (72.6% vs 72.4%). A significant drop in SVO2 was
noted after ICA occlusion during balloon inflation, and this
was statistically significant in comparison with baseline (P
.003), in comparison with CCA occlusion (P  .018) and
in comparison with ICA flow reversal (P  .015). The
decrease in oxygen saturation during ICA occlusion in five
patients who sustained a hypotensive carotid body response
was not different (P  1.0) from that occurring in five
patients who did not sustain hypotension with ICA balloon
occlusion during angioplasty.
Fig 2. Intraoperative substraction angiogram illustrating
internal jugular vein. Note (white arrows) a third introd
monitoring. With the common carotid artery occluded
through the sheath and antegrade flow is seen in the IC
opened, and digital substraction is maintained until contr
the tubing into the jugular vein (right, black arrows).
cerebral protection with ICA flow reversal is in place forDISCUSSION
Carotid artery angioplasty and stenting without cere-
bral protection is associated with a significant risk of new
cerebral infarction and neurologic events secondary to em-
bolization.2 The initial guidewire crossing of the carotid
lesion is associated with the highest risk of cerebral embo-
lization during CAS.5 Therefore, a major limitation of
internal carotid balloon occlusion and filtering methods of
cerebral protection is that they do not prevent emboliza-
tion during the initial guidewire crossing of the carotid
lesion. To resolve this problem, Parodi and colleagues3,6
developed a cerebral protection method using a guiding
catheter with an elastomeric balloon at the tip that occludes
the CCA and allows reversal of ICA flow by connecting the
catheter with the femoral vein, while the external carotid
artery is occluded with another balloon. This method of
cerebral protection has been shown to eliminate cerebral
embolization detected by transcranial Doppler scanning
during CAS.7 However, the Parodi catheter, because of its
length, may result in a high-resistance conduit that limits
the arteriovenous gradient, mostly when balloon or stent
shafts occupy the lumen of the guiding catheter. Our
transcervical approach provides a shorter, larger caliber
arteriovenous conduit that permits higher, unimpeded ICA
flow reversal during the procedure. Obstruction of ICA
rsal of flow from the internal carotid artery (ICA) to the
sheath in the internal jugular vein for cerebral oxygen
the Rummel loop, contrast is injected into the ICA
ft black arrow), the arteriovenous fistula is immediately
seen flowing retrogradely in the ICA and finally through
sequence ascertains functioning of the fistula and that
rocedure.reve
ucer
with
A (le
ast is
This
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tion using the transcervical approach is minimal because the
catheters cross only the 11 cm of the CCA introducer
sheath, whereas the Parodi catheter requires catheter shafts
to cross its entire length from femoral to carotid. Therefore,
we believe that our method may produce a higher flow,
more reliable, less impeded ICA flow reversal than the
Parodi catheter.
The principle of cerebral protection from embolization
during ICA flow reversal is simple: particulate debris is
drawn from the ICA and CCA into a deep vein, avoiding its
embolization into the ICA when antegrade flow is re-
established. However, the mechanism of neurologic toler-
ance of ICA flow reversal is not well understood. Clinically
apparent cerebral ischemia occurs in 5% of patients under-
going carotid endarterectomy under regional anesthesia,
with neurologic signs developing only after at least 20
minutes of ICA occlusion in one half of the cases.8 In our
experience, none of seven patients who underwent ICA
flow reversal during 20 or more minutes developed ipsilat-
eral hemispheric symptoms.
During ICA flow reversal, blood is actually drawn out
of the ipsilateral hemisphere, and it appears counter-intui-
tive that it would be neurologically tolerated as well or
better than ICA occlusion alone. Our study suggests neu-
rologic tolerance to ICA flow reversal; it also suggests that
ICA flow reversal produces only a mild decrease in hemi-
spheric oxygen saturation and that this decrease is compa-
rable to that occurring during CCA occlusion with pre-
served external to internal carotid flow, but less than that
occurring during ICA transient balloon inflation during
angioplasty. Interestingly, transient neurologic symptoms
have been reported in 15% of patients undergoing CAS
with ICA balloon occlusion devices,9 not an insignificant
proportion of cerebral intolerance. This difference supports
Fig 3. Mixed venous oxygen saturation (SVO2) in the in
minutes after common carotid artery occlusion with e
occlusion with ICA flow reversal, immediately after ICA
*Statistically different from baseline; **statistically diffe
represent mean O2 saturation  SD. (CCA, common
reversed in the ICA).the concept that ICA flow reversal may be better tolerated
than ICA occlusion.
It is plausible that during ICA flow reversal the ipsilat-
eral hemispheric vascular resistance is decreased (compared
with ICA occlusion), facilitating inflow from all other po-
tential collateral channels, and that this hemodynamic re-
arrangement preserves hemispheric oxygenation. The nat-
ural metabolic reserve and extensive hemispheric collateral
pathways of the brain probably have enough capacity to
compensate for all the different hemodynamic situations
produced by the different cerebral protection methods. For
this reason, differences in neurologic tolerance to the vari-
ous protection methods may not be clinically apparent.
The response to ICA balloon inflation produced a
significantly drop in cerebral oxygen saturation in our
study. This immediate response, which is difficult to ex-
plain, did not appear time dependent. It is possible that it
could be partly secondary to an intracerebral reflex mecha-
nism in response to carotid balloon angioplasty. Since our
ICA balloon inflation was very brief, we do not know
whether the hemispheric SVO2 would have remained low
or would have recovered with prolonged ICA occlusion.
This phenomenon could have been also related to the
hypotensive response secondary to carotid body stimula-
tion, but our data suggest that O2 saturation was not
different in patients sustaining hypotension compared with
those without a hypotensive response to transient ICA
balloon inflation. Leisch et al’s10 report is in line with our
experience, with its finding that 40% of patients undergoing
CAS sustained a reaction secondary to carotid body stimu-
lation during balloon inflation, most commonly short-term
hypotension without clinical symptoms, not associated to
periprocedural cerebral complications.
It is important to realize that our data are preliminary
and our conclusions should be viewed with caution because
al jugular vein during carotid stenting at baseline, 1 to 2
al to internal carotid flow preservation, during CCA
ioplasty balloon inflation, and upon return to baseline.
than the 3 values to the left. Numbers under columns
d artery; ICA, internal carotid artery; Flow rever., flowtern
xtern
ang
rent
caroti
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 1 Criado et al 97of the small number of patients involved in the study. It is
likely that multiple factors are involved in neurologic toler-
ance to ICA flow reversal; our study provides, however,
limited information. Hemispheric cerebral perfusion and
metabolic studies will be required to elucidate subtle, but
perhaps important, differences in cerebral physiology pro-
duced by the different cerebral protection methods.
In summary, our data suggest that ICA flow reversal for
cerebral protection during CAS is well tolerated because
hemispheric cerebral oxygenation is only mildly decreased,
to a degree comparable to that occurring during CCA
occlusion with preservation of any possible external to
internal carotid flow. Additionally, ICA balloon dilatation
appears to be associated with the sharpest, immediate de-
cline in cerebral oxygenation during CAS. Further investi-
gation is necessary to better understand cerebral physiology
during ICA flow reversal.
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